Emboline
Latest round
- Series D
Last raised
- May 2021
Total raised
- $58M
Investors
- 4
About Emboline
Emboline, Inc.Founded in 2011 in Santa Cruz, US, Emboline, Inc. specializes in developing medical devices for heart intervention. In March 2026, Emboline, Inc.Emboline, Inc. specializes in the development of innovative medical devices designed to enhance safety during interventional heart procedures, particularly the Emboliner® Total Embolic Protection Catheter. This proprietary catheter addresses a significant health risk associated with transcatheter aortic valve replacement (TAVR) procedures—specifically, the release of embolic debris into the bloodstream which can lead to stroke and long-term neurological impairment. The Emboliner® device is designed to capture and remove these emboli before they can affect the brain and other critical organs, providing a crucial layer of protection for patients undergoing TAVR. The company is actively engaged in clinical trials, including the Protect the Head to Head IDE trial, aiming to validate the efficacy and safety of their product.Emboline generates revenue through direct sales of its medical devices, particularly the Emboliner® Total Embolic Protection Catheter, to hospitals and healthcare providers involved in cardiovascular interventions. Transactions typically occur through established contracts with healthcare institutions, which may involve bulk purchasing agreements for usage in specific procedures. The business model is primarily B2B, where hospitals acquire these devices for patient treatments rather than direct-to-consumer sales. Pricing structures for the Emboliner® catheter may involve negotiated rates based on volume, institutional partnerships, and any additional services or support the company provides. The ongoing clinical trials and studies enhance the credibility of the product and create pathways for future sales opportunities as they demonstrate the device's clinical effectiveness and safety in real-world applications.
Who invested in Emboline
4 investors across 2 rounds
See all investors in Emboline
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Emboline
Who invested in Emboline?
Emboline has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Emboline raised?
Emboline has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Emboline last raise money?
Emboline's most recent round on record is a Series D, in May 2021.
What does Emboline do?
Emboline is a medical devices & equipment company.
Where is Emboline headquartered?
Emboline is headquartered in Santa Cruz, US.
Which VCs invest in companies like Emboline?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Emboline's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Emboline? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.